These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25928658)

  • 61. A meta-analysis quantifying transmission parameters of FMDV strain O Taiwan among non-vaccinated and vaccinated pigs.
    Eblé PL; de Koeijer AA; de Jong MC; Engel B; Dekker A
    Prev Vet Med; 2008 Jan; 83(1):98-106. PubMed ID: 17683815
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reduction of foot-and-mouth disease virus transmission in cattle vaccinated one or two weeks before challenge using a commercial polyvalent vaccine.
    Duffy S; Fondevila N; Galdo Novo S; Aznar M; Garro C; Smitsaart E; Monti G
    Vaccine X; 2020 Aug; 5():100063. PubMed ID: 32368734
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dromedaries (Camelus dromedarius) are of low susceptibility to inoculation with foot-and-mouth disease virus serotype O.
    Alexandersen S; Wernery U; Nagy P; Frederiksen T; Normann P
    J Comp Pathol; 2008 Nov; 139(4):187-93. PubMed ID: 18789453
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transmission of foot-and-mouth disease by vaccinated cattle following natural challenge.
    Donaldson AI; Kitching RP
    Res Vet Sci; 1989 Jan; 46(1):9-14. PubMed ID: 2537993
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Foot-and-mouth disease virus infection in young lambs: pathogenesis and tissue tropism.
    Ryan E; Horsington J; Durand S; Brooks H; Alexandersen S; Brownlie J; Zhang Z
    Vet Microbiol; 2008 Mar; 127(3-4):258-74. PubMed ID: 17942248
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recombinant non-structural polyprotein 3AB-based serodiagnostic strategy for FMD surveillance in bovines irrespective of vaccination.
    Mohapatra JK; Pandey LK; Sanyal A; Pattnaik B
    J Virol Methods; 2011 Nov; 177(2):184-92. PubMed ID: 21864578
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early events in the pathogenesis of foot-and-mouth disease in cattle after controlled aerosol exposure.
    Pacheco JM; Arzt J; Rodriguez LL
    Vet J; 2010 Jan; 183(1):46-53. PubMed ID: 18930417
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnostic application of recombinant non-structural protein 3A to detect antibodies induced by foot-and-mouth disease virus infection.
    Biswal JK; Ranjan R; Pattnaik B
    Biologicals; 2016 May; 44(3):157-62. PubMed ID: 26995490
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity.
    Quattrocchi V; Bianco V; Fondevila N; Pappalardo S; Sadir A; Zamorano P
    Dev Biol (Basel); 2004; 119():481-97. PubMed ID: 15742663
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pathogenesis and micro-anatomic characterization of a cell-adapted mutant foot-and-mouth disease virus in cattle: Impact of the Jumonji C-domain containing protein 6 (JMJD6) and route of inoculation.
    Lawrence P; Pacheco J; Stenfeldt C; Arzt J; Rai DK; Rieder E
    Virology; 2016 May; 492():108-17. PubMed ID: 26914509
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of antibodies transferred by colostrum in the immune responses of calves to current foot-and-mouth disease vaccines.
    Bucafusco D; Di Giacomo S; Pega J; Juncos MS; Schammas JM; Pérez-Filgueira M; Capozzo AV
    Vaccine; 2014 Nov; 32(48):6576-82. PubMed ID: 24968156
    [TBL] [Abstract][Full Text] [Related]  

  • 73. FOOT-AND-MOUTH DISEASE IN A SMALL SAMPLE OF EXPERIMENTALLY INFECTED PRONGHORN (ANTILOCAPRA AMERICANA).
    Rhyan J; McCollum M; Gidlewski T; Shalev M; Ward G; Donahue B; Arzt J; Stenfeldt C; Mohamed F; Nol P; Deng M; Metwally S; McKenna T; Salman M
    J Wildl Dis; 2016 Oct; 52(4):862-873. PubMed ID: 27525593
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Understanding the molecular epidemiology of foot-and-mouth-disease virus.
    Klein J
    Infect Genet Evol; 2009 Mar; 9(2):153-61. PubMed ID: 19100342
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody.
    Sørensen KJ; de Stricker K; Dyrting KC; Grazioli S; Haas B
    Arch Virol; 2005 Apr; 150(4):805-14. PubMed ID: 15645377
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination.
    Bergmann IE; Malirat V; Neitzert E
    Biologicals; 2005 Dec; 33(4):235-9. PubMed ID: 16257539
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vaccination against foot-and-mouth disease II: Regaining FMD-free status.
    Backer JA; Engel B; Dekker A; van Roermund HJ
    Prev Vet Med; 2012 Nov; 107(1-2):41-50. PubMed ID: 22726463
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Marker vaccine potential of foot-and-mouth disease virus with large deletion in the non-structural proteins 3A and 3B.
    Biswal JK; Subramaniam S; Ranjan R; Sharma GK; Misri J; Pattnaik B
    Biologicals; 2015 Nov; 43(6):504-11. PubMed ID: 26260689
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Unapparent foot and mouth disease infection (sub-clinical infections and carriers): implications for control.
    Sutmoller P; Casas OR
    Rev Sci Tech; 2002 Dec; 21(3):519-29. PubMed ID: 12523693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.